This is one of the Elliot wave possibilities for Laurus Labs from perspective. Please do not construe this as a financial advise
NATCO PHARMA made a rounding bottom and later completed the cup and handle pattern. The stock is trying to reverse from the 38% retracement from the top it made recently. If it reverses we can aim for the target of 1240-1300-1350-1500-1600. Targets or studies are based on my analysis and shouldn't be considered as BUY/ SELL recommendation.
SMS Pharma is showing absolute strength and expected to break this barrier soon. Target as per my study should be 199-248-291-310 NOTE: I'm not a SEBI REG. Study before investing.
LLY shown on a daily chart has doubled in the past year with the introduction of new FDA approved drugs into the market. It has but out a series of favorable earnings reports with optimistic realistic guidance and glowing analysts' forecasts. It has done so without any volume pumps and just keeps grinding higher. This is because it is in the shadows of big...
Cipla give us good movement in past days and now it also give us breakout . Buy cipla at 1412 Target 1505 1580 1650 Sl 1366
Technically Pharma index is on the verge of giving a cup and handle like breakout in addition to news of new COVID variant making waves. The Pharma index also looking very buoyant. If this particular index can give a closing above 16515 there can be an upsurge 16734 or even 17177 levels taking the index constituents higher along with it. Major companies in...
Pharma Sector and its components are in correction phase NSE:CNXPHARMA sectors NSE:DIVISLAB , NSE:SUNPHARMA , NSE:DRREDDY have created same structure as NSE:NIFTY NSE:DIVISLAB , NSE:SUNPHARMA , NSE:DRREDDY daily candle close below level. We can see all targets along with NSE:NIFTY , $NSE:CNXMETAL. Disclaimer - All information on this page...
This is a Technical Analysis on Moderna (MRNA) on the 1 Week Timeframe. Current price action shows that we are currently in the process of breaking a MAJOR SUPPORT Zone. We held critical SUPPORT multiple times ABOVE the $115.00 level, for a span of about 26 months. Expressed by the GREEN circles. But notice we havent been able to successfully rally and stay...
There is M pattern breakdown in CIpla on dally chart pattern.
My simple logic on apollo hospital with upper trendline.
the stock broke the trend line and ready to push for 0.618 fib levels ..best for long term investment. 50 MA golden cross coming soon..
Short Term Trading Advice by Goodluck Capital Buy Cipla Limited (NSE:CIPLA) Buy Range- 1175 - 1200 Target- 1275 - 1300 StopLoss- below 1150 Potential Return- 7-9% Approx trade duration 12 - 14 days
Hello & Welcome to this analysis The outlook has been down from quarterly, monthly, weekly & daily chart study. Its been in a 2 years downtrend, now near a support but yet to give any reversal confirmation. If this level of 700 fails to hold the next major support comes in at 600. Overall its a wait and watch stock even from a bounce back point of view
#DEEPAKNTR.. ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
Axsome Therapeutics Inc (AXSM) I have been in this spot trade since $50.77. We are now at $72.93. I have much higher targets as you can see from the chart. This is a long term trade looking to hold for 12 – 24 months however feel that something is going to happen within 6 – 12 months based on the chart. - Forming pennant on chart and RSI. Potential for...
NSE:ALKEM Stock is consolidating between 3350 to 3450 approximately a month. Price 3350 is holding as good support. Currently we can see there is a morning star pattern(Bullish Pattern) at support which is a sign of strength. We can go long at these levels and keep SL below swing. The stock should not open gap down on 28th June. Following to this check 1hr...
The pool-season is about to start, and Merck has already secured its place on the water slide, which should take it further downwards below the support at $110.66. However, there is still a 35% chance that the share might catch a bubbling fountain which could push it above the resistance at $119.65. In that case, we would expect Merck to develop a new top in the...
VRPX was on a downtrend from mid-February into a reversal the beginning of May. VRPX beat earnings up still has no cash flow which is very common in this subsector. VRPX is priced on the potential of future earnings. The short and long-moving averages ratio shows bullish momentum also shows strength with an upper Bollinger Band "walk". Price has climbed...